Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT05035420
Eligibility Criteria:
* INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
* Provision of signed and dated informed consent form.
* Stated willingness to comply with all study procedures and availability for the duration of the study.
* Male or female aged 18 years or greater.
* In good general health as evidenced by medical history with no signs of cough, sneeze and upper respiratory symptoms.
* Body temperature in normal range (afebrile, temperature \< 100.4 (Infinite) F) on the day of the experiment.
EXCLUSION CRITERIA:
* Any skin disease.
* Fever (Temperature greater than or equal to 100.4 degrees F).
* Any past or present cardiovascular or pulmonary diseases.
* Known adverse reaction to latex.
* Any medical condition that, in the opinion of the Principal Investigator would preclude the inclusion of a patient onto this research study.
* Unable or unwilling to give informed consent.
* Individuals with known respiratory conditions.
* Individuals who are currently taking medication that may cause methemoglobinemia such as nitrates derivatives, sulfonamides, dapsone, phenacetin, phenazopyridine, some local anesthetics such as prilocaine, topical anesthetics such as emla cream, benzocaine.
* Individuals with history of seizure.
* Smokers and those on narcotics.
* Pregnant women are excluded due to risk associated to hypercapnia risk
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
78 Years
Study:
NCT05035420
Study Brief:
Protocol Section:
NCT05035420